Tiziana Life Sciences (Nasdaq: TLSA) Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough neuro-immunomodulation therapies, today announced an upcoming oral presentation, titled, “Treatment of PIRA with Nasal Foralumab Dampens Microglial Activation and Stabilizes Clinical Progression in Non-Active Secondary Progressive MS” that will be presented during the “Multiple […]

Skye Bioscience (OTCQB: SKYE) Uplists to The Nasdaq Global Market

SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, with an emphasis on obesity and ocular indications, announced today that the Company has received approval […]

Interactive Strength Inc. (Nasdaq: TRNR) to Exhibit CLMBR at FIBO Global Fitness, the World’s Largest Trade Show for Fitness, Wellness and Health on April 11-14

FIBO Global Fitness Expects to Have More Than 150,000 Visitors for the Trade Show in Cologne, Germany CLMBR is Receiving Significant Interest From International Boutique Fitness Operators and Gym Chains AUSTIN, TX – (NewMediaWire) – April 10, 2024 – Interactive Strength Inc. (Nasdaq: TRNR) (“TRNR” or “the Company”), maker of innovative specialty fitness equipment and […]

Laser Photonics (NASDAQ: LASE) & Brokk Announce Technology Partnership To Integrate Game-Changing Laser Systems Into Industry-Leading Robotics

ORLANDO, Fla., April 10, 2024–(BUSINESS WIRE)–Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global developer of industrial laser systems for laser cleaning and other material processing applications, and Brokk Inc., the world’s leading manufacturer of remote-controlled robotic machines, announced that they have formed a technology partnership to bring laser cleaning and cutting technology to the mining, tunneling, […]

Laser Photonics (NASDAQ: LASE) Secures Order From L3Harris Technologies for LaserTower Marking & Engraving System

ORLANDO, Fla., April 09, 2024–(BUSINESS WIRE)–Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global developer of industrial laser systems for laser cleaning and other material processing applications, announced that it received an order for its LaserTower COMPACT marking and engraving system from L3Harris Technologies, Inc. “Laser Photonics is proud to supply laser marking equipment to L3Harris, one of the […]

Company Retires $2.6 Million Convertible Note

Company Currently Has No Outstanding Convertible Investments Remaining Bakersfield, CA, April 09, 2024 (GLOBE NEWSWIRE) — Trio Petroleum Corp (NYSE American: “TPET”, “Trio” or the “Company”), a California-based oil and gas company, announced that on April 8, 2024, filed a Form 8-K with the Securities and Exchange Commission (“SEC”) detailing the terms and conditions under […]

OKYO Pharma (NASDAQ: OKYO) to Reschedule Key Opinion Leader Event in Dry Eye Disease to May 2024

LONDON and NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA […]

Inspire Veterinary Partners (NASDAQ:IVP) Reports Full Year 2023 Financial Results

Full year 2023 revenue increases approximately 70% year-over-year to $16.7 million Outlook for growth in the pet health sector remains attractive with active pipeline of acquisition opportunities Implemented cost reduction initiatives to maximize operational efficiency to deliver profitable growth Major reduction of consultant fees and other discretionary expenses post IPO SG&A savings of at least […]

Longeveron (NASDAQ: LGVN) Announces Pricing of $5.25 Million Public Offering

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, today announced the pricing of a public offering of 2,234,043 shares of the Company’s Class […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.